The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium
暂无分享,去创建一个
R. Goldbohm | A. Miller | P. A. van den Brandt | C. Friedenreich | J. Palmer | M. McCullough | X. Shu | L. Brinton | J. Lissowska | L. Bernstein | A. Miller | B. Henderson | S. Gapstur | T. Rohan | P. Horn-Ross | K. Anderson | K. Robien | S. Olson | Y. Xiang | C. Schairer | Yikyung Park | J. Lacey | L. Schouten | Wanghong Xu | I. De Vivo | Hannah P. Yang | A. Magliocco | L. Wise | H. Hochster | V. Setiawan | N. Wentzensen | L. Cook | L. Rosenberg | M. Gaudet | I. Vivo | P. Brandt | J. Prescott | L. Kolonel | A. Felix | X. Ou Shu | R. Rastogi | C. Friedenreich | W-H Xu | H. P. Yang | A. Patel | X. Liang | R. Virkus | Y. Xiang | Y. Park | P. Horn‐Ross | Radhai Rastogi | Xiaowen Liang
[1] E. Weiderpass,et al. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases. , 2012, Maturitas.
[2] E. Pukkala,et al. Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas. , 2011, Gynecologic oncology.
[3] E. Oliva,et al. Cytogenetic and molecular aberrations in endometrial stromal tumors. , 2011, Human pathology.
[4] C. la Vecchia,et al. Metabolic syndrome and endometrial cancer risk. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] T. Rohan,et al. A Prospective Study of Inflammation Markers and Endometrial Cancer Risk in Postmenopausal Hormone Nonusers , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[6] F. Clavel-Chapelon,et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study , 2010, Endocrine-related cancer.
[7] J. Prat. FIGO staging for uterine sarcomas , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[8] Shannon M. Lynch,et al. Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium , 2009, Cancer Causes & Control.
[9] G. Rennert,et al. The risk of developing uterine sarcoma after tamoxifen use , 2007, International Journal of Gynecologic Cancer.
[10] J. Olsen,et al. Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors , 2005, Cancer Epidemiology Biomarkers & Prevention.
[11] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[12] R. Broaddus,et al. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] M. Zhan,et al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. , 2004, Gynecologic oncology.
[14] M. Sherman,et al. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus , 2003, Cancer.
[15] W. McCluggage,et al. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas , 2002, International Journal of Gynecologic Cancer.
[16] A. Venn,et al. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients. , 2001, Gynecologic oncology.
[17] K. Chang,et al. Utility of CD10 in Distinguishing between Endometrial Stromal Sarcoma and Uterine Smooth Muscle Tumors: An Immunohistochemical Comparison of 34 Cases , 2001, Modern Pathology.
[18] H. Adami,et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden) , 2000, Cancer Causes & Control.
[19] W. Thompson,et al. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus , 1996, Cancer.
[20] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[21] W. Thompson,et al. Incidence of histologic types of uterine sarcoma in relation to menstrual and reproductive history , 1991, International journal of cancer.
[22] S. Schwartz,et al. Marital status and the incidence of sarcomas of the uterus. , 1990, Cancer research.
[23] S. Schwartz,et al. A case—control study of risk factors for sarcomas of the uterus , 1989, Cancer.
[24] Ivar Heuch,et al. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. , 1988, Cancer research.
[25] N. Weiss,et al. The epidemiology of sarcomas of the uterus. , 1986, Journal of the National Cancer Institute.
[26] M. Chorváth,et al. [Uterine Sarcomas - a review]. , 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.
[27] C. Guillemette,et al. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. , 2011, The Journal of clinical endocrinology and metabolism.
[28] R. Hayes,et al. Cancer Causes & Control , 2004, Cancer Causes & Control.